Is Ocugen Stock a “Buy” Right Now?

Ocugen Inc (Nasdaq: OCGN) recently saw a gain of over 800%. So what happens now?

Compass Therapeutics IPO Set for $50 Million Nasdaq Offering

The Compass Therapeutics IPO is set to raise $50 million on November 13. But is Compass Therapeutics stock a good investment opportunity?